Navigation Links
Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany

tural course of the disease. Nearly 15 to 20% of these patients suffer from moderate to severe allergic rhinitis and rhino-conjunctivitis, not controlled by their usual medical treatment.

Since 2003, Stallergenes has been carrying out the Oralair programme which addresses these unmet medical needs with EBM-documented, registered allergen tablets that are safe and easy-to-use.

This programme consists in the development of the four main allergens accounting for more than 80% of the epidemiology of these allergies: grass pollens, house dust mites, birch pollen and ragweed pollen.

The entire programme is in the clinical development stage and is proceeding according to schedule.

About Oralair(R) Grasses

With a safe and easy-to-use daily dose of Oralair(R) Grasses, patients enjoy a very significant alleviation of all their rhino-conjunctivitis symptoms, a marked reduction in their symptomatic medication use and a noticeable improvement in their quality of life.

Oralair(R) Grasses is a fast-dissolving tablet that has demonstrated high efficacy in allergic rhino-conjunctivitis to grass pollen in the first season, throughout the pollen season and at the pollen peak on:

- poly- and mono-sensitised patients, as well as asthmatic patients,

- every individual symptom, and in peculiar in nasal congestion and

watery eyes

Oralair(R) Grasses is a pre-coseasonal treatment: it has to be started four months before the pollen season, maintained throughout the season, then stopped and restarted the following season.

Oralair(R) Grasses contains a mix of 5 standardised grass allergens: perennial rye grass (Lolium perenne), meadow grass (Poa pratensis), timothy grass (Phleum pratense), cocksfoot (Dactylis glomerata) and sweet vernal grass (Anthoxanthum odoratum), as a daily dose of 300 IR, so as to mimic patients' natural exposure.

The clinical development programme has already enrolled around 1600 p

SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
2. Stallergenes : 3rd Quarter Sales Up 17%: 9- Month Cumulative Sales Up 17%
3. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
4. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
5. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
6. STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
8. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
9. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
10. Barr Receives Approval for Generic Combunox(R) Tablets, 5mg/400mg
11. Mylan Announces Tentative FDA Approval for Lamotrigine Tablets
Post Your Comments:
(Date:10/8/2015)... ... October 08, 2015 , ... ... exclusive license agreement to develop and commercialize intellectual property rights belonging to The ... from February 2009, and affords exclusive worldwide rights to intellectual property based on ...
(Date:10/7/2015)... India , October 8, 2015 /PRNewswire/ ... --> Medical biotechnology accounts for largest ... of bioinformatics in drug discovery and development ... . ... On the basis of applications, the ...
(Date:10/7/2015)... ... October 07, 2015 , ... Neil Riordan, PhD to ... Summit Tomorrow, October 8th, at Mar-a-Lago from 3:50 pm to 4:30 pm. , Dr. ... cell therapy. , He is the Co-Founder and Chief Science Officer of ...
(Date:10/7/2015)...  ChromaDex Corp. (OTCQX: CDXC), an innovator of ... science-based solutions for dietary supplement, food and beverage, ... announced that the October 1 presentation from ... available for on-demand viewing at ...   --> LINK: ...
Breaking Biology Technology:
... ImQuest Life Sciences today presented important new results ... molecules as antiviral agents at the 13th International ... held last week in Washington D.C. ImQuest,s ... of HBV replication, with two compounds yielding potent ...
... be Released Concurrent with AHA PresentationSAN FRANCISCO, March 31 ... a biotechnology company focused on the development of compounds ... announced that an abstract on the Company,s Phase 2 ... poster presentation at the American Heart Association Arteriosclerosis, Thrombosis ...
... Linked to Anti-Viral Agents -- , ... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today ... further strengthens the company,s intellectual property leadership in ... of life-threatening diseases. The new patent grants ...
Cached Biology Technology:
(Date:10/5/2015)... -- ) releases the ... NXTD ), a biometric authentication company focused on ... ) releases the following market and company ... biometric authentication company focused on the growing mobile commerce ... ) releases the following market and company ...
(Date:9/30/2015)... Sept. 30, 2015  The global glucose monitoring device and ... So says a new report on the industry from Kalorama ... dominate the market, followed by continuous glucose monitoring and sensor ... the market for these products in its latest report, ... , ...
(Date:9/28/2015)... , September 28, 2015 ... expected to reach USD 12.03 billion by 2020, growing ... Technological advancements such as Backside Illumination (BSI) technique to ... over the forecast period.      (Logo: ... of the chip to reduce loss and, thus, reduce ...
Breaking Biology News(10 mins):
... German . Toxins from Bacillus thuringiensis ... conventional farming to manage pest insects. Sprayed as pesticides or ... in pest control since 1938, minimize herbivory in crops, such ... producing transgenic crops have been grown, which successfully control pests ...
... at the San Diego Supercomputer Center (SDSC) and ... (Calit2) at the University of California, San Diego, ... from the National Science Foundation (NSF) to create ... will develop new tools to help manage ever-growing ...
... 18, 2011 Acclaimed UC Irvine geneticist Francisco J. Ayala, ... and evolution, will donate $10 million to the School of ... faculty member, will be funded with profits from flourishing vineyards ... things, you should do them," said the University Professor and ...
Cached Biology News:
50 assays. Provides an easy system for rapid separation of cytosol and particulate fractions that are compatiable with downstream studies....
Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25....
Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...
... For real-time or pre-programmed liquid ... electrochemistry, or general liquid-handling research ... millisecond accuracy. Run ... Microprocessor-based for accuracy and ...
Biology Products: